Skip to main content

Table 2 Disease-free survival by clinical and disease characteristics

From: Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies

Factor

Progressors/Total

3-y DFS (%)

p-value

T-stage

  

0.99

T1-2

6/14

69

 

T3-4

5/10

56

 

Lymph Node Mets

  

0.14

N0/N1

2/8

86

 

N2

9/16

49

 

Tumor Grade

  

0.61

Low

3/5

53

 

High

8/19

64

 

Perineural Inv.

  

0.29

Absent

4/11

70

 

Present

7/13

55

 

Age

  

0.86

< 55

4/9

50

 

> 55

7/15

71

 

Gender

  

0.28

Male

6/16

72

 

Female

5/8

44

 

Dose > 63 Gy

  

0.81

Yes

6/15

63

 

No

5/9

50

 

TFHX

  

0.17

Yes

3/12

80

 

No

8/12

45